{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:58:38Z","timestamp":1761155918580},"reference-count":23,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.jbspin.2015.01.020","type":"journal-article","created":{"date-parts":[[2015,3,14]],"date-time":"2015-03-14T04:48:01Z","timestamp":1426308481000},"page":"362-364","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["New onset of articular inflammatory manifestations in patients with hidradenitis suppurativa under treatment with infliximab"],"prefix":"10.1016","volume":"82","author":[{"given":"Emilie","family":"Acquacalda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian Hubert","family":"Roux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Albert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00e9ronique","family":"Breuil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thierry","family":"Passeron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liana","family":"Euller-Ziegler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2015.01.020_bib0120","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/j.1468-3083.2009.03356.x","article-title":"Hidradenitis suppurativa","volume":"23","author":"Revuz","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jbspin.2015.01.020_bib0125","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1365-2559.1993.tb00468.x","article-title":"Granulomatous hidradenitis suppurativa and cutaneous Crohn's disease","volume":"23","author":"Attanoos","year":"1993","journal-title":"Histopathology"},{"key":"10.1016\/j.jbspin.2015.01.020_bib0130","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1365-2230.2005.01897.x","article-title":"Pyoderma gangrenosum associated with hidradenitis suppurativa","volume":"30","author":"Ah-Weng","year":"2005","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jbspin.2015.01.020_bib0135","first-page":"185","article-title":"SAPHO syndrome associated with hidradenitis suppurativa successfully treated with infliximab and methotrexate","volume":"69","author":"De Souza","year":"2011","journal-title":"Bull NYU Hosp Jt Dis"},{"key":"10.1016\/j.jbspin.2015.01.020_bib0140","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/00054725-200111000-00008","article-title":"Hidradenitis suppurativa and Crohn's disease: response to treatment with infliximab","volume":"7","author":"Mart\u00ednez","year":"2001","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jbspin.2015.01.020_bib0145","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jaad.2009.06.050","article-title":"Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: a randomized, double-blind, placebo-controlled crossover trial","volume":"62","author":"Grant","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jbspin.2015.01.020_bib0150","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1529-8019.2012.01471.x","article-title":"Paradoxical effect of infliximab in a patient with hidradenitis suppurativa","volume":"25","author":"Gori","year":"2012","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jbspin.2015.01.020_bib0155","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1684\/ejd.2012.1795","article-title":"Efficacy and tolerance of prolonged infliximab treatment of moderate-to-severe forms of hidradenitis suppurativa","volume":"22","author":"Lesage","year":"2012","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jbspin.2015.01.020_bib0160","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1365-2133.2011.10328.x","article-title":"New-onset polyarthritis during successful treatment of hidradenitis suppurativa with infliximab","volume":"165","author":"Van Rappard","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jbspin.2015.01.020_bib0165","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.jaad.2013.04.032","article-title":"Systematic review of the efficacy and adverse events associated with infliximab treatment of hidradenitis suppurativa in patients with coexistent inflammatory diseases","volume":"69","author":"Machet","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jbspin.2015.01.020_bib0170","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jbspin.2012.07.017","article-title":"Lichen planus under anti-TNF therapy for ankylosing spondylitis","volume":"80","author":"Wendling","year":"2013","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2015.01.020_bib0175","first-page":"434","article-title":"New-onset psoriatic palmoplantaris pustulosis following infliximab therapy: a class effect?","volume":"34","author":"Roux","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2015.01.020_bib0180","first-page":"S1297","article-title":"Paradoxical psoriatic arthritis in a patient with rheumatoid arthritis treated by TNF\u03b1 blocker","author":"Villani","year":"2014","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2015.01.020_bib0185","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1365-2133.2008.08728.x","article-title":"Review and expert opinion on prevention and treatment of infliximab-related infusion reactions","volume":"159","author":"Lecluse","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jbspin.2015.01.020_bib0190","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1136\/ard.2003.006270","article-title":"Septic arthritis caused by Moraxella catarrhalis associated with infliximab treatment in a patient with undifferentiated spondarthritis","volume":"63","author":"Olivieri","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2015.01.020_bib0195","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/RHU.0b013e318278b84c","article-title":"Pyoderma gangrenosum, acne conglobata, suppurative hidradenitis, and axial spondyloarthritis: efficacy of anti-tumor necrosis factor\u00a0\u03b1 therapy","volume":"18","author":"Bruzzese","year":"2012","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.jbspin.2015.01.020_bib0200","first-page":"684","article-title":"The clinical spectrum of the arthropathy associated with hidradenitis suppurativa and acne conglobata","volume":"20","author":"Rosner","year":"1993","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2015.01.020_bib0205","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1136\/ard.53.1.64","article-title":"Arthritis associated with hidradenitis suppurativa","volume":"53","author":"Bhalla","year":"1994","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2015.01.020_bib0210","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1097\/00007611-199109000-00023","article-title":"Reactive arthritis due to hidradenitis suppurativa mimicking osteomyelitis","volume":"84","author":"Tallo","year":"1991","journal-title":"South Med J"},{"key":"10.1016\/j.jbspin.2015.01.020_bib0215","doi-asserted-by":"crossref","first-page":"490","DOI":"10.3899\/jrheum.130977","article-title":"Hidradenitis suppurativa associated with spondyloarthritis \u2013 results from a multicenter national prospective study","volume":"41","author":"Richette","year":"2014","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2015.01.020_bib0220","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2174\/157488412803305821","article-title":"An overview of interleukin-1 receptor antagonist, anakinra, in the treatment of cutaneous diseases","volume":"7","author":"Pazyar","year":"2012","journal-title":"Curr Clin Pharmacol"},{"key":"10.1016\/j.jbspin.2015.01.020_bib0225","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jaad.2010.12.025","article-title":"Pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH): a new auto-inflammatory syndrome distinct from PAPA syndrome","volume":"66","author":"Braun-Falco","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jbspin.2015.01.020_bib0230","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1001\/jamadermatol.2013.5377","article-title":"Successful treatment of severe hidradenitis suppurativa with anakinra","volume":"149","author":"Zarchi","year":"2013","journal-title":"JAMA Dermatol"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X1500038X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X1500038X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,30]],"date-time":"2020-08-30T21:38:48Z","timestamp":1598823528000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X1500038X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S1297319X1500038X"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2015.01.020","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New onset of articular inflammatory manifestations in patients with hidradenitis suppurativa under treatment with infliximab","name":"articletitle","label":"Article Title"},{"value":"Joint Bone Spine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbspin.2015.01.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Soci\u00e9t\u00e9 fran\u00e7aise de rhumatologie. Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}